Category Archives: News

Board changes to further growth at Cell Therapies Pty Ltd

Cell Therapies Pty Ltd (Cell Therapies), a leading manufacturer and distributor of cellular therapies in the Asia-Pacific region, is pleased to announce significant change to board structure in anticipation of the next stage of corporate growth. Following successful restructuring of Cell Therapies’ growth strategy and new CEO recruitment, Dr Christian Behrenbruch will step down as […]

Cell Therapies Joins Innovative $60 Million Government Research Centre

      Cell Therapies Pty Ltd is an essential partner in a new $60 million Commonwealth Government project designed to help translate promising cellular therapy treatments from the lab bench to the marketplace. The Cooperative Research Centre for Cell Therapy Manufacturing is a $59 million, six-year project funded by $20 million in cash from […]

Cell Therapies P/L joins CRC for Cell Therapy Manufacturing (CRC-CTM)

Cell Therapies P/L has become an essential partner in the recently approved Cooperative Research Center for Cell Therapies Manufacturing (CRC-CTM). The combination of world leading academic researchers with local and overseas commercial companies is a novel feature of the Australian Government sponsored CRC program. The CRC-CTM’s research is directed towards improved manufacturing capabilities and lowered […]

New Chairman Appointed by Cell Therapies

Cell Therapies Pty Ltd is pleased to announce that Dr Christian Behrenbruch has been appointed as Chairman of the Melbourne-based life sciences company. Dr Behrenbruch will also serve as a nominee non-executive director on behalf of the Peter MacCallum Cancer Centre, the major shareholder of Cell Therapies. Dr Behrenbruch has a demonstrated track record of […]

Cell Therapies Gains Access to Innovative Cartilage Product

Cell Therapies has announced an exclusive licensing agreement with South Korean-based Medipost for the distribution and manufacture of its innovative product Cartistem® a cellular treatment for osteoarthritis (OA) and focal defects of the knee CARTISTEM® is the world’s first therapeutic agent approved for treating degenerative arthritis and knee cartilage defects, which is based on stem […]